SCHEMBL3779883

SCHEMBL3779883

Cc1c(CO)no[n+]1[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13685915 0.78
SCHEMBL13055305 0.77 CA12 (0.40)
SCHEMBL20377309 0.76 CA12 (0.37)
SCHEMBL14000571 0.75 CA12 (0.39)
SCHEMBL14000536 0.75 CA12 (0.39)
SCHEMBL28321395 0.72
SCHEMBL2079547 0.71 GLA (0.58)
SCHEMBL8936076 0.71 GLA (0.44)
SCHEMBL8936017 0.71 CATSPER1 (0.39)
SCHEMBL9213055 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10456405-B2 Nitric oxide-releasing prodrug molecule of substituted quinazolines ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD (CN) 2019-10-29 US disclosed
CN-106032378-B New A RB compound and application thereof 武汉启瑞药业有限公司 2019-10-25 CN disclosed
US-20180250305-A1 NITRIC OXIDE-RELEASING PRODRUG MOLECULE ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. (CN) 2018-09-06 US disclosed
EP-3348548-A1 NITRIC OXIDE-RELEASING PRODRUG MOLECULE Zhejiang Huahai Pharmaceutical Co., Ltd (CN) 2018-07-18 EP disclosed
US-9708306-B2 Benzimidazole derivatives and preparation process and pharmaceutical uses thereof WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD (CN) 2017-07-18 US disclosed
US-20170172970-A1 VECTOR DELIVERY-BASED MICROBICIDES RUSH UNIVERSITY MEDICAL CENTER (US) 2017-06-22 US disclosed
US-20170172970-A1 VECTOR DELIVERY-BASED MICROBICIDES RUSH UNIVERSITY MEDICAL CENTER (US) 2017-06-22 US disclosed
US-9603841-B2 Vector delivery-based microbicides RUSH UNIVERSITY MEDICAL CENTER (US) 2017-03-28 US disclosed
US-9603841-B2 Vector delivery-based microbicides RUSH UNIVERSITY MEDICAL CENTER (US) 2017-03-28 US disclosed
US-20170022188-A1 Benzimidazole Derivatives and Preparation Process and Pharmaceutical Uses Thereof WUHAN LL SCIENCE AND TECHNOLOGY DEVELOPMENT CO., LTD. (CN) 2017-01-26 US disclosed
US-9233101-B2 2016-01-12 US disclosed
US-9233101-B2 2016-01-12 US disclosed
US-20100331404-A1 Vector Delivery-Based Microbicides RUSH UNIVERSITY MEDICAL CENTER (US) 2010-12-30 US disclosed
US-20100331404-A1 Vector Delivery-Based Microbicides RUSH UNIVERSITY MEDICAL CENTER (US) 2010-12-30 US disclosed
US-7595313-B2 Nitric oxide donating diuretic compounds, compositions and methods of use NICOX, S.A. (FR) 2009-09-29 US disclosed
US-20080287407-A1 Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use NITROMED, INC. (US) 2008-11-20 US disclosed
US-20080255101-A1 NITRIC OXIDE DONATING DIURETIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE NITROMED, INC. (US) 2008-10-16 US disclosed
US-7396829-B2 such as 2H-1,2,4-benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-3-[5-(nitrooxy)pentyl]-, 1,1-dioxide; contains at least one nitric oxide enhancing group; excessive water or electrolyte retention conditions; cardiovascular diseases, and diseases resulting from oxidative or endothelial dysfunctions NITROMED, INC. (US) 2008-07-08 US disclosed
WO-2007022082-A2 VECTOR DELIVERY-BASED MICROBICIDES RUSH UNIVERSITY MEDICAL CENTER (US) 2007-02-22 WO disclosed
WO-2007022082-A2 VECTOR DELIVERY-BASED MICROBICIDES RUSH UNIVERSITY MEDICAL CENTER (US) 2007-02-22 WO disclosed